2021
DOI: 10.1016/j.nantod.2021.101229
|View full text |Cite
|
Sign up to set email alerts
|

Design, optimization, and nanotechnology of antimicrobial peptides: From exploration to applications

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
112
0
1

Year Published

2021
2021
2023
2023

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 184 publications
(132 citation statements)
references
References 308 publications
2
112
0
1
Order By: Relevance
“…Because of the special membrane active action and antimicrobial performance, AMPs are increasingly becoming the hot topic at the field of antibiotic candidates in fighting against the emerging drug resistant bacterial infection ( del Rosso et al, 2019 ; Zhang et al, 2020 ). Although the antimicrobial performance and research potency are promising, the clinical application of AMPs still faces great challenges such as manufacturing costs, safety, bioactivity, rational design strategy, and so on ( Tan et al, 2021 ; Wang et al, 2021 ), which makes it important to explore the novel design strategy to design AMPs with high cell selectivity ( Shao et al, 2020 ). It has been well discussed that the Trp residues played an important role in the antimicrobial activity of linear a-helical antimicrobial peptide by deeply inserting into the negatively charged bacterial membrane, and the penetration of AMPs into the bacterial membrane could be enhanced without causing obvious binding activity to the membrane of mammalian cells when the Trp residues occurred at the hydrophobic-hydrophilic interface ( Song et al, 2019 ).…”
Section: Discussionmentioning
confidence: 99%
“…Because of the special membrane active action and antimicrobial performance, AMPs are increasingly becoming the hot topic at the field of antibiotic candidates in fighting against the emerging drug resistant bacterial infection ( del Rosso et al, 2019 ; Zhang et al, 2020 ). Although the antimicrobial performance and research potency are promising, the clinical application of AMPs still faces great challenges such as manufacturing costs, safety, bioactivity, rational design strategy, and so on ( Tan et al, 2021 ; Wang et al, 2021 ), which makes it important to explore the novel design strategy to design AMPs with high cell selectivity ( Shao et al, 2020 ). It has been well discussed that the Trp residues played an important role in the antimicrobial activity of linear a-helical antimicrobial peptide by deeply inserting into the negatively charged bacterial membrane, and the penetration of AMPs into the bacterial membrane could be enhanced without causing obvious binding activity to the membrane of mammalian cells when the Trp residues occurred at the hydrophobic-hydrophilic interface ( Song et al, 2019 ).…”
Section: Discussionmentioning
confidence: 99%
“…However, there are only a few available for clinical use, such as bacitracin and polymyxin [ 36 ]. Antimicrobial peptides are easily degraded by protease and lose their antibacterial activity, which leads to the limitations of clinical application [ 3 ]. Among them, trypsin is a very important digestive enzyme ubiquitous in mammals, which mainly attacks the arginine and lysine of proteins or polypeptides [ 37 ].…”
Section: Discussionmentioning
confidence: 99%
“…The emergence of new antibiotic-resistant bacteria means that clinical treatment is facing a great crisis. Therefore, the development of new antibacterial agents has become an urgent task [ 3 ]. Antimicrobial peptides (AMPs) are considered ideal candidates to replace antibiotics because of their strong potential against multidrug-resistant bacteria and their unique mechanism of action; that is these peptides are currently the main focus of research [ 3 , 4 , 5 ].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Futhermore, Thr supplementation may suppress the inflammatory cytokine synthesis by inhibiting the TLR4 signal pathway to improve intestinal immune function [7]. Antimicrobial peptides in the gut also contribute to the intestinal immune response [102]. A recent study found that L-Thr at the concentration of 1mM upregulates β-defensin (pBD-1, pBD-2, and pBD-3) expression by activating NF-κB signaling and inhibiting sirtuin-1 (SIRT1) expression in porcine intestinal epithelial cells [103].…”
Section: Immune Functionmentioning
confidence: 99%